---
document_datetime: 2023-09-21 18:00:10
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/jalra-epar-all-authorised-presentations_en.pdf
document_name: jalra-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.5360222
conversion_datetime: 2025-12-19 00:03:47.128911
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU number       | Invented name   | Strength   | Pharmaceutical   | Route of       | Packaging               | Package size        |
|-----------------|-----------------|------------|------------------|----------------|-------------------------|---------------------|
|                 |                 |            | Form             | Administration |                         |                     |
| EU/1/08/485/001 | Jalra           | 50 mg      | Tablet           | Oral use       | Blister (PA/Al/PVC//Al) | 7 tablets           |
| EU/1/08/485/002 | Jalra           | 50 mg      | Tablet           | Oral use       | Blister (PA/Al/PVC//Al) | 14 tablets          |
| EU/1/08/485/003 | Jalra           | 50 mg      | Tablet           | Oral use       | Blister (PA/Al/PVC//Al) | 28 tablets          |
| EU/1/08/485/004 | Jalra           | 50 mg      | Tablet           | Oral use       | Blister (PA/Al/PVC//Al) | 30 tablets          |
| EU/1/08/485/005 | Jalra           | 50 mg      | Tablet           | Oral use       | Blister (PA/Al/PVC//Al) | 56 tablets          |
| EU/1/08/485/006 | Jalra           | 50 mg      | Tablet           | Oral use       | Blister (PA/Al/PVC//Al) | 60 tablets          |
| EU/1/08/485/007 | Jalra           | 50 mg      | Tablet           | Oral use       | Blister (PA/Al/PVC//Al) | 90 tablets          |
| EU/1/08/485/008 | Jalra           | 50 mg      | Tablet           | Oral use       | Blister (PA/Al/PVC//Al) | 112 tablets         |
| EU/1/08/485/009 | Jalra           | 50 mg      | Tablet           | Oral use       | Blister (PA/Al/PVC//Al) | 180 tablets         |
| EU/1/08/485/010 | Jalra           | 50 mg      | Tablet           | Oral use       | Blister (PA/Al/PVC//Al) | 336 tablets         |
| EU/1/08/485/011 | Jalra           | 50 mg      | Tablet           | Oral use       | Blister (PA/Al/PVC//Al) | 336 (3x112) tablets |